Comparison between Claris Lifesciences IPO and MOIL IPO.
Claris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while MOIL IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Claris Lifesciences IPO is up to ₹300.00 Cr whereas the issue size of the MOIL IPO is up to ₹1,237.51 Cr. The final issue price of Claris Lifesciences IPO is ₹228.00 per share and of MOIL IPO is ₹375.00 per share.
| Claris Lifesciences IPO | MOIL IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹228.00 per share | ₹340.00 per share |
| Issue Price (Upper) | ₹235.00 per share | ₹375.00 per share |
| Issue Price (Final) | ₹228.00 per share | ₹375.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹18.75 per share |
| Discount (Employee) | ₹18.75 per share | |
| Market Lot Size | 22 shares | 17 shares |
| Fresh Issue Size | 1,26,32,477 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 3,36,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,237.51 Cr |
| Issue Size Total | 1,26,32,477 shares | 3,36,00,000 shares |
| Issue Size Total (Amount) | up to ₹300.00 Cr | up to ₹1,237.51 Cr |
Claris Lifesciences IPO opens on Nov 24, 2010, while MOIL IPO opens on Nov 26, 2010. The closing date of Claris Lifesciences IPO and MOIL IPO is Dec 02, 2010, and Dec 01, 2010, respectively.
| Claris Lifesciences IPO | MOIL IPO | |
|---|---|---|
| Anchor Bid Date | Nov 23, 2010 | |
| Issue Open | Nov 24, 2010 | Nov 26, 2010 |
| Issue Close | Dec 02, 2010 | Dec 01, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 20, 2010 | Dec 15, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Claris Lifesciences IPO P/E ratio is , as compared to MOIL IPO P/E ratio of .
| Claris Lifesciences IPO | MOIL IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 86.03 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 0.69 | 80 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1455.05 Cr. | ₹6300.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 24.15 | 27.77 |
In the Claris Lifesciences IPO Retail Individual Investors (RII) are offered 37,89,743 shares while in MOIL IPO retail investors are offered 37,89,743 shares. Qualified Institutional Buyers (QIB) are offered 57,36,484 shares in Claris Lifesciences IPO and 1,64,64,000 shares in MOIL IPO.
| Claris Lifesciences IPO | MOIL IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,43,003 shares | |
| Market Maker Reservation | ||
| QIB | 57,36,484 shares | 1,64,64,000 shares |
| NII | 12,63,247 shares | 49,39,200 shares |
| RII | 37,89,743 shares | 1,15,24,800 shares |
| Employee | 6,72,000 shares | |
| Others | ||
| Total | 1,26,32,477 shares | 3,36,00,000 shares |
Claris Lifesciences IPO subscribed 1.50x in total, whereas MOIL IPO subscribed 56.44x.
| Claris Lifesciences IPO | MOIL IPO | |
|---|---|---|
| QIB (times) | 1.31x | 49.16x |
| NII (times) | 2.03x | 143.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.60x | 32.86x |
| Employee (times) | 0.57x | |
| Other (times) | ||
| Total (times) | 1.50x | 56.44x |
